In this cross‐sectional biomarker study, we assessed the correlates of early microglial and astrocytic responses in preclinical AD and their effects on downstream changes in the amyloid cascade, including soluble CSF p‐tau181, neurogranin, t‐tau, and NfL. The gene discussed is NRGN; the disease is Alzheimer disease.